Evidence map›Paper›PMID 39945358›Full record

ArticleDisease models & mechanisms2025

A bacterial artificial chromosome mouse model of amyotrophic lateral sclerosis manifests 'space cadet syndrome' on two FVB backgrounds.

Sophie E Badger, Ian Coldicott, Ergita Kyrgiou-Balli, Adrian Higginbottom, Chloé Moutin, Kamallia Mohd Imran, John C Day, Johnathan Cooper-Knock, Richard J Mead, James J P Alix

Abstract read
In one paragraph

Article in Disease models & mechanisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sophie E BadgerSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 1HQ, UK.ORCID 0009-0009-3696-8578
Ian ColdicottSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 1HQ, UK.
Ergita Kyrgiou-BalliSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 1HQ, UK.
Adrian HigginbottomSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 1HQ, UK.
Chloé MoutinSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 1HQ, UK.
Kamallia Mohd ImranSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 1HQ, UK.
John C DayInterface Analysis Centre, School of Physics, University of Bristol, Bristol BS8 1TL, UK.
Johnathan Cooper-KnockSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 1HQ, UK.
Richard J MeadSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 1HQ, UK.
James J P AlixSheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield S10 1HQ, UK.ORCID 0000-0001-8391-9749

Funding

Motor Neurone Disease Association Alix/Apr19/871-791University of Sheffield
6 · The paper itself

Abstract

C9orf72-related amyotrophic lateral sclerosis (ALS)/frontotemporal dementia (FTD) has proven difficult to model in mice. Liu et al. (2016) reported a bacterial artificial chromosome (BAC) transgenic mouse displaying behavioural, motor and pathological abnormalities. This was followed by multiple laboratories independently refuting and confirming phenotypes. A proposed explanation centred on the use of different FVB background lines (from The Jackson Laboratory and Janvier Labs). We studied C9orf72 BAC mice on both backgrounds and found significantly elevated levels of dipeptide repeat proteins, but no evidence of a transgene-associated phenotype. We observed seizures and a gradual decline in functional performance in transgenic and non-transgenic mice, irrespective of genetic background. The phenotype was in keeping with the so-called 'space cadet syndrome'. Our findings indicate that the differences previously reported are not due to C9orf72 status and highlight the importance of using genetic backgrounds that do not confound interpretation of neurodegenerative phenotypes.

Indexed as

Amyotrophic Lateral SclerosisChromosomes, Artificial, BacterialFrontotemporal DementiaGenetic BackgroundAnimalsC9orf72 ProteinDisease Models, AnimalMiceMice, TransgenicPhenotypeSeizuresC9orf72 ProteinAmyotrophic lateral sclerosisBacterial artificial chromosomeFrontotemporal dementiaFVB/NMouse modelSpace cadet syndrome

Identifiers

PMID39945358
PMCPMC11849976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.